HepA-I

BIOLOGICAL2 trials

Sponsors

Sinovac Biotech Co., Ltd, Institute of Medical Biology, Chinese Academy of Medical Sciences

Conditions

Hepatitis APolioPoliomyelitis

Phase 4

Booster Dose of sIPV Co-administered With MMR and HepA-I.

CompletedNCT06442449

Sinovac Biotech Co., LtdPoliomyelitis

Start: 2024-08-08End: 2025-10-10Updated: 2026-01-16

Phase IV Study of Concomitant Administration of the sIPV and HepA

Not yet recruitingNCT06460545

Institute of Medical Biology, Chinese Academy of Medical SciencesHepatitis A, Polio

Start: 2024-06-15End: 2027-12-15Target: 2000Updated: 2024-06-14

Related Papers

Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles-Mumps-Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial.

2025-10-23